Reagents, Specific, Analyte
Main Filters
Reagents, Specific, Analyte
| IQ Products B.V. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| IQP-568F | 0 | - | ||
| IQP-568R | 0 | - | ||
| IQP-569R | 0 | - | ||
| LIFE TECHNOLOGIES CORPORATION | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| A26922 | 0 | - | ||
| A26923 | 0 | - | ||
| A26924 | 0 | - | ||
| A26926 | 0 | - | ||
| A26929 | 0 | - | ||
| A26930 | 0 | - | ||
| A26934 | 0 | - | ||
| A26935 | 0 | - | ||
| CD0201 | 0 | - | ||
| CD02014 | 0 | - | ||
| CD0204 | 0 | - | ||
| CD0205 | 0 | - | ||
| CD0206 | 0 | - | ||
| CD0217 | 0 | - | ||
| CD0218 | 0 | - | ||
| CD0231 | 0 | - | ||
| CD0301 | 0 | - | ||
| CD0304 | 0 | - | ||
| CD0305 | 0 | - | ||
| CD0326 | 0 | - | ||
| CD0328 | 0 | - | ||
| CD0329 | 0 | - | ||
| CD0330 | 0 | - | ||
| CD0330TR | 0 | - | ||
| CD1001 | 0 | - | ||
| CD1004 | 0 | - | ||
| CD1005 | 0 | - | ||
| CD11700 | 0 | - | ||
| CD11704 | 0 | - | ||
| CD11705 | 0 | - | ||
| CD11718 | 0 | - | ||
| CD11B00 | 0 | - | ||
| CD11B01 | 0 | - | ||
| CD11B014 | 0 | - | ||
| CD11B04 | 0 | - | ||
| CD11B044 | 0 | - | ||
| CD64044 | 0 | - | ||
| H10104 | 0 | - | ||
| MHCD0705 | 0 | - | ||
| MHCD0817 | 0 | - | ||
| MHCD1928 | 0 | - | ||
| MHCD45054 | 0 | - | ||
| MHCD4530 | 0 | - | ||
| MHCD5904 | 0 | - | ||
| MHCD59044 | 0 | - | ||
| MHTDT015 | 0 | - | ||
| MHZAP7020 | 0 | - | ||
6,445 Results
Results Per Page
- 50
- 100
- 250
Catalog #
Available
Starting At
Name
Company Name
Description
0
-
CD64 R-PE
IQ Products B.V.
The R-PE conjugated monoclonal antibody CD64 (clone 32.2) binds a CD64 epitope distinct from the ligand-binding site and from the clone 32.2 antibody to CD64 epitope. It shows especially high affinity binding to human mononuclear phagocytes and polymorphonuclear leukocytes exposed to IFN-y or G-CSF. Its binding is not blocked in the presence of human IgG or immune complexes.CD64 reacts with the Fc gamma receptor 1 (FcyR1), a glycoprotein with a molecular weight of 72 kDa. The antigen is a high-affinity receptor for IgG and is able to bind human IgG1 and IgG3. The antigen is expressed on macrophages, monocytes, and interferon y (IFN-y) and Granulocyte Colony Stimulating Factor (G-CSF) stimulated neutrophils.
0
-
CD64 R-PE
IQ Products B.V.
The R-PE conjugated monoclonal antibody CD64 (clone 22) binds to a CD64 epitope distinct from the ligand-binding site and from the clone 32.2 antibody to CD64 epitope. It shows especially high affinity binding to human mononuclear phagocytes and polymorphonuclear leukocytes exposed to IFN-y or G-CSF. Its binding is not blocked in the presence of human IgG or immune complexes.CD64 reacts with the Fc gamma receptor 1 (FcyR1), a glycoprotein with a molecular weight of 72 kDa.The antigen is a high-affinity receptor for IgG and is able to bind human IgG1 and IgG3. The antigen is expressed on macrophages, monocytes, and interferon y (IFN-y) and Granulocyte Colony Stimulating Factor (G-CSF) stimulated neutrophils.
0
-
CD64 FITC
IQ Products B.V.
The FITC conjugated monoclonal antibody CD64 (clone 22) binds to a CD64 epitope distinct from the ligand-binding site and from the clone 32.2 antibody to CD64 epitope. It shows especially high affinity binding to human mononuclear phagocytes and polymorphonuclear leukocytes exposed to IFN-y or G-CSF. Its binding is not blocked in the presence of human IgG or immune complexes.CD64 reacts with the Fc gamma receptor 1 (FcyR1), a glycoprotein with a molecular weight of 72 kDa.The antigen is a high-affinity receptor for IgG and is able to bind human IgG1 and IgG3. The antigen is expressed on macrophages, monocytes, and interferon y (IFN-y) and Granulocyte Colony Stimulating Factor (G-CSF) stimulated neutrophils.